EMA: Two new combination therapies against chronic hepatitis C recommended for approval
May 30, 2016 – According to its News and Events section of the homepage, the European Medicines Agency (EMA) has recommended the granting of marketing authorisations in the European Union (EU) for two new combination therapies against chronic (long-term) hepatitis C virus (HCV) infection, namely …
EMA: Two new combination therapies against chronic hepatitis C recommended for approval Read more »